MedAssets Given New $28.00 Price Target at Robert W. Baird (MDAS)
Stock analysts at Robert W. Baird hoisted their price objective on shares of MedAssets (NASDAQ:MDAS) from $27.00 to $28.00 in a report issued on Thursday, American Banking News.com reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price would indicate a potential upside of 8.07% from the stock’s previous close.
A number of other firms have also recently commented on MDAS. Analysts at ISI Group raised their price target on shares of MedAssets from $23.50 to $28.00 in a research note to investors on Monday. They now have a “neutral” rating on the stock. Separately, analysts at Raymond James downgraded shares of MedAssets from a “strong-buy” rating to a “market perform” rating in a research note to investors on Tuesday, October 1st. Finally, analysts at Sterne Agee reiterated a “top pick” rating on shares of MedAssets in a research note to investors on Monday, September 16th. They now have a $30.00 price target on the stock, up previously from $25.00. Six investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. MedAssets currently has an average rating of “Buy” and an average price target of $26.83.
Shares of MedAssets (NASDAQ:MDAS) traded up 2.09% during mid-day trading on Thursday, hitting $25.91. 316,628 shares of the company’s stock traded hands. MedAssets has a 1-year low of $15.40 and a 1-year high of $25.72. The stock has a 50-day moving average of $24.35 and a 200-day moving average of $20.56. The company has a market cap of $1.586 billion and a P/E ratio of 378.81.
MedAssets (NASDAQ:MDAS) last released its earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.04. The company had revenue of $170.70 million for the quarter, compared to the consensus estimate of $167.64 million. During the same quarter in the previous year, the company posted $0.28 earnings per share. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, analysts predict that MedAssets will post $1.31 earnings per share for the current fiscal year.
MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.